Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)

Accolade Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	848.25	834.82	742.37	597.82	579.85	262.66
Other Revenue	10.37	10.37	10.95	7.61	5.16	-
Revenue	858.62	845.19	753.32	605.43	585.01	262.66
Revenue Growth (YoY)	7.00%	12.20%	24.43%	3.49%	122.72%	13.26%
Cost of Revenue	761.51	742.9	654.69	524.55	497.26	194.59
Gross Profit	97.12	102.29	98.62	80.89	87.74	68.08
Selling, General & Admin	31.04	31.73	32.36	30.34	25.53	16.03
Research & Development	27.29	27.27	25.89	19.03	14.16	9.3
Other Operating Expenses	5.3	4.8	3.38	4.76	2.87	1.62
Operating Expenses	64.2	65.32	62.52	54.45	42.52	26.28
Operating Income	32.91	36.97	36.11	26.43	45.22	41.8
Interest Expense	-6.67	-7.59	-7.48	-9.63	-10.76	-6.87
Interest & Investment Income	9.11	12.28	20.18	10.65	3.64	1.38
Currency Exchange Gain (Loss)	2.12	2.12	1.78	7.93	-1.34	-0.93
Other Non Operating Income (Expenses)	-0.59	-0.13	-0.12	-0.66	-0.06	-0.21
EBT Excluding Unusual Items	36.88	43.64	50.45	34.72	36.71	35.17
Gain (Loss) on Sale of Investments	-0.06	-0.06	-	-1.77	0.18	-
Gain (Loss) on Sale of Assets	-0.51	-0.51	-0.97	5.12	-0.72	-0.25
Other Unusual Items	4.22	4.12	3.81	14.51	2.17	0.74
Pretax Income	41.06	47.19	53.29	52.58	38.34	35.66
Income Tax Expense	12.23	11.68	9.76	5.55	3.1	5.33
Earnings From Continuing Operations	28.83	35.5	43.54	47.02	35.24	30.33
Minority Interest in Earnings	-	-	0.01	0.01	0.03	0.05
Net Income	28.83	35.5	43.55	47.04	35.27	30.38
Net Income to Common	28.83	35.5	43.55	47.04	35.27	30.38
Net Income Growth	-37.73%	-18.47%	-7.41%	33.34%	16.12%	201.97%
Shares Outstanding (Basic)	194	203	207	168	153	92
Shares Outstanding (Diluted)	194	203	207	168	153	92
Shares Change (YoY)	-9.06%	-2.31%	23.45%	9.53%	66.61%	0.66%
EPS (Basic)	0.15	0.18	0.21	0.28	0.23	0.33
EPS (Diluted)	0.15	0.18	0.21	0.28	0.23	0.33
EPS Growth	-31.53%	-16.55%	-25.00%	21.74%	-30.30%	200.00%
Free Cash Flow	-169.45	-254.34	-51.08	-89.13	-238.26	-169.42
Free Cash Flow Per Share	-0.88	-1.25	-0.25	-0.53	-1.55	-1.84
Dividend Per Share	0.060	0.060	0.080	0.070	-	-
Dividend Growth	-25.00%	-25.00%	14.29%	-	-	-
Gross Margin	11.31%	12.10%	13.09%	13.36%	15.00%	25.92%
Operating Margin	3.83%	4.37%	4.79%	4.37%	7.73%	15.91%
Profit Margin	3.36%	4.20%	5.78%	7.77%	6.03%	11.56%
Free Cash Flow Margin	-19.73%	-30.09%	-6.78%	-14.72%	-40.73%	-64.50%
EBITDA	100.29	101.59	89.71	68.3	81.62	53.13
EBITDA Margin	11.68%	12.02%	11.91%	11.28%	13.95%	20.23%
D&A For EBITDA	67.38	64.62	53.6	41.87	36.4	11.33
EBIT	32.91	36.97	36.11	26.43	45.22	41.8
EBIT Margin	3.83%	4.37%	4.79%	4.37%	7.73%	15.91%
Effective Tax Rate	29.79%	24.76%	18.31%	10.57%	8.08%	14.96%
Revenue as Reported	858.62	845.19	753.32	605.43	585.01	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.